Lewis MM - Search Results

1

D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease.

Lewis MM, Huang X, Nichols DE, Mailman RB. Lewis MM, et al. CNS Neurol Disord Drug Targets. 2006 Jun;5(3):345-53. doi: 10.2174/187152706777452245. CNS Neurol Disord Drug Targets. 2006. PMID: 16787233 Review.

2

Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.

Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE. Monte AP, et al. Among authors: lewis mm. J Med Chem. 1998 Jun 4;41(12):2134-45. doi: 10.1021/jm980076u. J Med Chem. 1998. PMID: 9622555

3

Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.

Lewis MM, Watts VJ, Lawler CP, Nichols DE, Mailman RB. Lewis MM, et al. J Pharmacol Exp Ther. 1998 Jul;286(1):345-53. J Pharmacol Exp Ther. 1998. PMID: 9655879

4

Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.

Doll MK, Nichols DE, Kilts JD, Prioleau C, Lawler CP, Lewis MM, Mailman RB. Doll MK, et al. Among authors: lewis mm. J Med Chem. 1999 Mar 11;42(5):935-40. doi: 10.1021/jm9804533. J Med Chem. 1999. PMID: 10072690

5

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.

Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB. Lawler CP, et al. Among authors: lewis mm. Neuropsychopharmacology. 1999 Jun;20(6):612-27. doi: 10.1016/S0893-133X(98)00099-2. Neuropsychopharmacology. 1999. PMID: 10327430

6

D1 dopamine receptors.

Huang X, Lawler CP, Lewis MM, Nichols DE, Mailman RB. Huang X, et al. Among authors: lewis mm. Int Rev Neurobiol. 2001;48:65-139. doi: 10.1016/s0074-7742(01)48014-7. Int Rev Neurobiol. 2001. PMID: 11526741 Review. No abstract available.

7

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.

Mottola DM, Kilts JD, Lewis MM, Connery HS, Walker QD, Jones SR, Booth RG, Hyslop DK, Piercey M, Wightman RM, Lawler CP, Nichols DE, Mailman RB. Mottola DM, et al. Among authors: lewis mm. J Pharmacol Exp Ther. 2002 Jun;301(3):1166-78. doi: 10.1124/jpet.301.3.1166. J Pharmacol Exp Ther. 2002. PMID: 12023552

8

Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs.

Kilts JD, Connery HS, Arrington EG, Lewis MM, Lawler CP, Oxford GS, O'Malley KL, Todd RD, Blake BL, Nichols DE, Mailman RB. Kilts JD, et al. Among authors: lewis mm. J Pharmacol Exp Ther. 2002 Jun;301(3):1179-89. doi: 10.1124/jpet.301.3.1179. J Pharmacol Exp Ther. 2002. PMID: 12023553

9

Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.

Qandil AM, Lewis MM, Jassen A, Leonard SK, Mailman RB, Nichols DE. Qandil AM, et al. Among authors: lewis mm. Bioorg Med Chem. 2003 Apr 3;11(7):1451-64. doi: 10.1016/s0968-0896(02)00561-8. Bioorg Med Chem. 2003. PMID: 12628671

10

8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.

Grubbs RA, Lewis MM, Owens-Vance C, Gay EA, Jassen AK, Mailman RB, Nichols DE. Grubbs RA, et al. Among authors: lewis mm. Bioorg Med Chem. 2004 Mar 15;12(6):1403-12. doi: 10.1016/j.bmc.2004.01.008. Bioorg Med Chem. 2004. PMID: 15018913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters